skeletal muscle relaxants

skeletal muscle relaxants

central nervous system-acting agents (e.g. baclofen, diazepam) used to reduce chronic muscle spasm/spasticity associated with multiple sclerosis
References in periodicals archive ?
A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions.
The authors note no difference between various NSAID agents or between skeletal muscle relaxants.
Compared to low doses, overdose risk is up to five times higher for patients taking moderate to high doses of opioids, and up to 20 times higher in those who use opioids at moderate to high doses together with benzodiazepines, skeletal muscle relaxants, or other sedative-hypnotic drugs, report Renu K.
They recommended considering nonsteroidal anti-inflammatory drugs or skeletal muscle relaxants for patients who want medications for acute or subacute low back pain.
NEJM Journal Watch notes in its analysis of the recommendations that within these reviews, there is evidence that skeletal muscle relaxants for acute pain may also be effective.
Among patients with acute nonspecific mechanical LBP, the most frequent pharmacological approach is the admin istration (or self-administration) of paracetamol, nonsteroidal anti-inflammatory drugs (NSAID) and skeletal muscle relaxants.
Chapter 7: Skeletal muscle relaxants and antispasticity drugs for orofacial pain disorders
Symptomatic treatment can be given with anti-inflammatory drugs and skeletal muscle relaxants.
They recommend considering nonsteroidal anti-inflammatory drugs or skeletal muscle relaxants for patients who want medications for acute or subacute low back pain.
The clinical management system reviews medications within certain drug categories that have the potential for abuse, including tranquillizers, skeletal muscle relaxants and anorexients/amphetamines.
Certain medications, such as controlled substances, tramadol-containing products and skeletal muscle relaxants are excluded from the program.
Narcotic analgesics, anticonvulsants, non-steroidal anti-inflammatory drugs, skeletal muscle relaxants and antidepressants represented 70% of total pharmacy costs and 74% of total transactions in 2008.